US2015266827A1PendingUtilityA1
Antibiotic Tolerance Inhibitors
Est. expiryFeb 22, 2031(~4.6 yrs left)· nominal 20-yr term from priority
A61P 31/00A61K 31/4184C07D 235/28C07D 405/12C07D 263/58A61K 31/496
39
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure relates to benzimidazole-benzamide derivatives, and the use thereof, e.g., to treat infections.
Claims
exact text as granted — not AI-modified1 . A compound of Formula I:
or a pharmaceutically acceptable salt thereof, wherein:
Y is (CH 2 ) p , O, or a bond;
Ring A is aryl, heteroaryl, heterocycloalkyl, substituted by 1 to 5 R 1 ;
R 1 is H, —NR a R b , NO 2 , or —NHC(O)R c ; or 2 R 1 together with the carbon atoms to which they are attached form a heteroaryl or heterocycloalkyl;
R 2 is H, C 1-6 alkyl, C 1-6 alkoxy, —NR a R b , —NHC(O)R a , NO 2 , —CN, —SR a , —S(O) 2 R a ;
R a and R b are each independently H or C 1-6 alkyl;
R c is H, C 1-6 alkyl, C 1-6 haloalkyl;
m is 1, 2, 3, or 4; and
p is 1, 2, 3, 4, 5, or 6.
2 .- 28 . (canceled)Join the waitlist — get patent alerts
Track US2015266827A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.